+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Fertility Drugs Market Report 2026 - Product Thumbnail Image

Fertility Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
Non-Opioid Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Non-Opioid Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 197 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Treatment Market Report 2026 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 236 Pages
  • Global
From
Intestinal Pseudo-Obstruction Treatment Market Report 2026 - Product Thumbnail Image

Intestinal Pseudo-Obstruction Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Epilepsy Treatment - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Treatment - Global Strategic Business Report

  • Report
  • August 2026
  • 483 Pages
  • Global
From
Loading Indicator